Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Dark Pool Levels


Bio-Techne Releases SARS-CoV-2 Multi-Antigen Serology


RTTNews | Oct 19, 2020 07:14AM EDT

07:13 Monday, October 19, 2020 (RTTNews.com) - Bio-Techne Corp. (TECH) announced that ProteinSimple, a Bio-Techne brand, released its SARS-CoV-2 Multi-Antigen Serology Module for Jess and Wes Simple Western automated western blotting systems. It is intended for research use only. The company said the serology assay accelerates COVID-19 research and vaccine development through rapid characterization of human immune response to multiple SARS-CoV-2 antigens.

The SARS-CoV-2 multi-antigen assay for Simple Western offers quantitative characterization of patient serum or plasma derived human IgG antibodies reactive against recombinant Nucleocapsid protein, S1 receptor binding domain protein, S1 subunit full length, S2 subunit full length, and Spike viral antigens within one 3-hour run.

Read the original article on RTTNews ( https://www.rttnews.com/3137113/bio-techne-releases-sars-cov-2-multi-antigen-serology-module-for-covid-19-research.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2020 RTTNews.com All Rights Reserved






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC